Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765698 · ClinicalTrials.gov registry record
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02765698: Clinical Trial study, sponsored by Mayo Clinic.
NCT02765698 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02765698 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing this information, then women in the future may be able to have less extensive surgery for their endometrial cancer after evaluation with PET/MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02765698
The ClinicalTrials.gov registry entry for NCT02765698 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02765698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02765698 about?
NCT02765698 is a clinical study titled "Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer". The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing th...
What is the current status of trial NCT02765698?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2016-05. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT02765698?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.